Financial impact of an outbreak of clinically diagnosed blackleg - a case study from Lao PDR

Clostridium septicum: A review in the light of alpha-toxin and development of vaccines

Clostridium septicum (CS) is a pathogen that can cause the death of animals in livestock worldwide through its main virulence factor, alpha-toxin (ATX). The aspects involved in diseases caused by ATX, such as economic impact, prevalence, and rapid clinical course, require that animals should be systematically immunized. This review provides an overview of CS in livestock farming and discusses current immunization methods. Currently, commercial vaccines available against CS involve the cultivation and inactivation of microorganisms and toxins using a time-consuming, expensive, and high biological risk-carrying production platform, and some have been reported to be ineffective. An alternative to this process is the recombinant DNA technology, although recombinant ATX obtained thus far is no longer efficient in stimulating protective antibody titers despite improvements in the production methods. On the other hand, immunized animals have highly favorable levels of survival when subjected to challenge tests, suggesting that high titers of circulating serum antibodies may not be representative of protection after immunization and that the non-immune cellular defenses associated with the particularities of the mechanism of action of ATX may be involved in the immune response of the host. To contribute to the future of global livestock farming through the development of more efficient recombinant vaccines, we suggest novel perspectives and strategies, such as the location of immunodominant epitopes, expression of relevant functional domains, and construction of chimeras, in the rational design of recombinant ATX.

Improved Milk Production from Supplementation of Swamp Buffalo with Molasses Nutrient Blocks Containing 10% Urea

Milk production from Asiatic swamp buffalo is a new enterprise in Laos. As yields are limited, provision of high-quality cow-calf molasses nutrient blocks containing 10% urea (UMNB10) may improve productivity. A trial in a recently established commercial buffalo dairy examined dietary supplementation of lactating buffalo cows with UMNB10, with three groups of nine cows in mid-lactation randomly selected. Two groups received ad libitum access to UMBs with the remaining group free of block supplements. All animals were daily fed fresh Napier grass (30 kg), corn (750 gm), rice bran (1.45 kg), plus accessed fresh Mulatto grass. Daily milk production (DMP) and body condition score (BCS) were recorded for the 2 months of access to UMB. Average DMP for the two supplemented groups were 1.02 and 0.96 L, compared to 0.78 L for the control group, suggesting improved milk productivity of 31 and 24% from accessing UMB. Partial budget analysis identified a strong incentive for use of the molasses blocks, with a net profit of USD 408 and USD 295 over a 30-day period for the supplemented groups. A multi-intervention livestock development strategy that includes a combination of nutritional and health interventions has been proposed for scale-out to assist smallholder livestock farming efficiency in developing countries. The use of high-quality molasses blocks may be a simple motivator for these communities to increase the efficiency of large ruminant production, improving rural livelihoods, food security, and potentially, reducing greenhouse gas emissions (GHGe) from ruminant-derived foods.

Managing Welfare and Antimicrobial-Resistance Issues in Treating Foot-and-Mouth Disease Lesions: A New Therapeutic Approach

Introduction

Foot-and-mouth disease (FMD) causes negative impacts on global food security, the livestock trade, national economies, and farming-family livelihoods, particularly in resource-poor developing countries with inadequate biosecurity and low levels of vaccination from inadequate veterinary services. As smallholder farmers have limited understanding of disease-risk management, their focus in FMD outbreaks is on accessing clinically effective therapies. However, most are provided inappropriate traditional treatments and/or topical or parenteral antibiotics, often delivered by paraveterinarians inadequately trained in antimicrobial custodianship. This results in negative financial impacts on livelihoods plus risks of food safety and development of antimicrobial resistance. We report the use of a novel pain-relief therapy for FMD.

Methods

Clinical examinations in an outbreak of suspected FMD in April 2019 in Muang Khay village in Luang Prabang province, Laos confirmed signs and lesions of severe, subacute, ulcerative glossitis and interdigital dermatitis, typical of FMD. All affected buffalo (n=99) and cattle (n=37) presented for treatment in a population of 238 large ruminants, from 15 of 136 households, were administered a topical anesthetic pain-relief product (PRP) wound gel by spray-on (10–30 mL per animal) formulation developed for aversive husbandry procedures (Tri-Solfen, Animal Ethics, Australia).

Results

Treatment with PRP resulted in immediate improvement in demeanor and locomotion, and no adverse events were observed. On follow-up interview, all owners confirmed that their animals were eating within 2 days and lesions had healed within 5 days. Having experienced the positive clinical impacts of PRP on affected animals, these and surrounding farmers were keen to purchase the PRP for future use. The veterinary authorities rapidly registered the PRP for FMD therapy in Laos due to the observed efficacy.

Discussion

These findings suggest a potential paradigm shift from treating FMD with expensive antimicrobials, which risks antimicrobial resistance, to a new, less expensive therapeutic approach that reduces animal suffering and may motivate farmers to report disease to access treatment. Use of the PRP is suggested as an innovation that may improve future FMD management, particularly in developing countries.

Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use:

https://youtu.be/RpGDU5808CA